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Abstract To determine the relationship between 25(OH)
vitamin D levels and non-melanoma skin cancer (NMSC),
we performed a nested case–control study in ambulatory,
elderly men enrolled in the Osteoporotic Fractures in Men
(MrOS) Study. Health habit and medical history, including
self-reported history of NMSC were recorded and
25(OH)D levels were measured on serum collected at
baseline from a random sample of Caucasian MrOS sub-
jects. Mean age (73 ± 5), BMI, daily vitamin D and cal-
cium intake were similar in the men with (n = 178) and
without NMSC (n = 930), but higher levels of 25(OH)D
were associated with a decreased risk of having a history of
NMSC (Ptrend = 0.04). Men in the highest quintile of
25(OH)D ([30 ng/mL) had 47% lower odds of NMSC
(95% CI: 0.30–0.93, p = 0.026) compared to those in the
lowest quintile. Our results suggest that a diagnosis of
NMSC is not a surrogate for adequate 25(OH)D levels or
increased UV exposure, and high 25(OH)D levels may be
associated with a reduced risk of NMSC.
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Introduction
Non-melanoma skin cancer (NMSC) affects close to 1
million Americans annually. Although metastases are rare,
their high incidence and frequent recurrence in affected
individuals make NMSCs the 4th most costly cancers of
the Medicare population [1]. NSMC is comprised of two
subtypes—squamous cell carcinomas (SCC) and basal cell
carcinomas (BCC). The majority of NMSCs are of the
BCC subtype in older, white subjects (4:1 ratio of
BCC:SCC) [2]. Public health education campaigns advo-
cate sunscreen use and sun avoidance for prevention, but
the incidence of NMSC continue to rise [2, 3].
NMSC is caused at least in part by sunlight [2] and sun-
lightisalsotheprimarysourceofvitamin D[4].Thelevelof
25(OH)D,themajorcirculatingformofvitaminD,iswidely
acceptedasthebestindicatorofvitaminDstatusandvitamin
D deﬁciency occurs if 25(OH)D levels are\20 ng/mL and
insufﬁciency if \30 ng/mL. There is increasing evidence
that vitamin D may be protective against cancers of the
colon, breast, and prostate [5]. Observational data and one
interventional clinical trial suggest that higher levels of
25(OH)Dareassociatedwithreducedvisceralcancerrisk[4,
6,7].Thus,basedontheideathattheriskofNMSCisrelated
to the amount of ultraviolet (UV) exposure, a diagnosis of
NMSChasbeenusedasasurrogateforhigh25(OH)Dlevels
[8–10,11].NMSCsubjectshavebeenhypothesizedtohavea
reducedriskofvisceralcancers,butthedataareinconsistent.
TwostudiesshowedthatNMSCsubjectshaveareducedrisk
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increased risk for colorectal and visceral cancers [11, 12].
Therehasbeennostudycomparing 25(OH)Dlevelsandrisk
for NMSC. We initially hypothesized that NMSC subjects
would have higher 25(OH)D levels given their chronic
exposure to UV. To determine the association 25(OH)D
levels and risk for NMSC, we conducted a nested case-
control study in a cohort of elderly men.
Methods
Study participants
Subjects were participants in the Osteoporotic Fractures in
Men Study (MrOS), a prospective cohort study of risk
factors for fracture. During the baseline examination from
March 2000 to April 2002, 5,995 community-dwelling men
65 years or older were recruited from population-based
listings at six clinical centers in the United States: Bir-
mingham, AL; Minneapolis, MN; Palo Alto, CA; Portland,
OR; Pittsburgh, PA; and San Diego, CA. MrOS enrollees
represent a relatively healthy and highly educated popu-
lation [13, 14].
Analysis of serum 25(OH)D
At the baseline visit, 1,608 randomly selected MrOS par-
ticipantshadfastingmorningbloodcollected,andserumwas
prepared immediately and stored at -70C in vials foil-
wrapped to prevent light exposure. Measures for 25(OH)D2
(derived from ergocalciferol and obtained from nutritional
supplements and plants such as sun-dried mushrooms) and
25(OH)D3 (derived from cholecalciferol and obtained
primarily from UV irradiation, fortiﬁed foods, and supple-
ments) were performed at the Mayo Clinic Labs using LC-
mass spectroscopy[15]. Duplicate pooled serum controls
were included. The inter-assay coefﬁcient of variation was
4.4% and the intra-assay coefﬁcient of variation was 4.9%.
Almost all circulating total 25(OH)D levels measured were
due to 25(OH)D3 [16] and we deﬁne 25(OH)D as 25(OH)D3
in our analysis as we sought to measure endogenous vitamin
D3 produced from UV irradiated skin. Levels of 25(OH)D2
weredetectedin26%ofsamplesandcontributedtolessthan
10% of the total 25(OH) [16]. Because levels of 25(OH)D
vary by race/ethnicity, we limited our analysis to Caucasian
men (n = 1,441).
Non-melanoma skin cancer outcome and covariates
At the baseline and the 5-year follow-up visit, MrOS par-
ticipants responded to a questionnaire item that inquired
about having a history of NMSC (‘‘Has a doctor or health
care provider ever told you that you have skin cancer (not
melanoma)’’ and asked their age at ﬁrst NMSC diagnosis.
1,234 subjects out of 1,441 subjects had evaluable
responses. We deﬁned the group without NMSC as those
participants who answered ‘‘no’’ to ever having skin cancer
at both the baseline and 5-year visits (n = 930). We
deﬁned the NMSC group (n = 178) as those subjects who
answered ‘‘yes’’ to ever having skin cancer at both the
baseline and the 5-year visits or who answered ‘‘yes’’ to
ever having NMSC at the 5-year visit and whose age at ﬁrst
skin cancer diagnosis was consistent with a diagnosis
before the baseline visit. Incident NMSC cases (n = 100)
were deﬁned as those subjects who answered ‘‘no’’ to ever
having skin cancer at baseline and ‘‘yes’’ to skin cancer at
the 5 year visit and whose age a ﬁrst skin cancer diagnosis
was consistent with diagnosis after the baseline visit. Other
studies have demonstrated that patient self-reported history
of NMSC has a positive predictive value of 95.1% and a
negative predictive value of 85.9% [17].
Covariates were obtained by self-administered ques-
tionnaire at the baseline visit [13, 14]. Physical activity was
quantiﬁed using the physical activity scale for the elderly
(PASE) and ‘‘walking outdoors’’ for exercise was used as a
proxy for outdoor activity [18]. Total calcium and vitamin
D intake (from foods and supplements) in the past
12 months were estimated using a modiﬁed block food
frequency questionnaire (Block Dietary Data Systems,
Berkeley, CA). UV exposure history of each subject was
estimated by participant’s clinic site (to determine latitude)
and walking outdoors physical activity [6]. UV exposure is
a major confounder as increased UV exposure contributes
to NMSC risk and raises 25(OH)D levels.
Statistical analysis
We used univariate and multivariable logistic regression to
determine a dose-response association between serum
25(OH)D and odds of NMSC. Quintiles of 25(OH)D were
based on the distribution of 25(OH)D in the NMSC and no
NMSC groups. Odds of NMSC for quintiles Q2 through Q5
were compared with the lowest quintile. We calculated 95%
conﬁdence intervals and used the Mantel extension test to
evaluate the presence of linear trend across quintiles. We
tested for an interaction between 25(OH)D per ng/mL and
each of the covariates; age, PASE walking score and clinic
site for effect modiﬁcation on the association of 25(OH)D3
with NMSC and reported the p value for interaction.
Results
Baseline characteristics for men with and without NSMC
weresimilarinmeanage(73.4 ± 5.5 years),BMI,smoking,
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(Table 1). The mean value of 25(OH)D for the entire cohort
was 23 ng/mL and consistent with reported values in the
persons [70 years of age in the US population[16, 19].
Subjects with NMSC diagnosis had slightly lower levels of
outdoor walking activity (p = 0.02) and minimally higher
(22 IU) daily vitamin D intake (p = 0.05). The average age
of skin cancer development was 61 ± 12 years, approxi-
mately 10 years prior to the median age at which blood for
assessing vitamin D status was collected.
As a measure of consistency, we investigated the asso-
ciation of known predictors to serum 25(OH)D levels in
univariate analyses. As expected, increasing age was sig-
niﬁcantly associated with decreasing 25(OH)D levels
(p\0.0001) [16] likely due to the age-related decline in
vitamin D status due to decreasing amounts of the vitamin
D precursor, 7-dehydrocholesterol in the skin [4]. Partici-
pants who resided near a clinic with higher UV exposure
(San Diego) had higher levels of 25(OH)D compared to
participants residing in clinics in Minnesota and Portland
(p\0.0001) as previously reported [16].
As a measure of internal validity, we examined the
effect of a number of known risk factors for NMSC
(Table 2). Subjects residing in Minneapolis or Portland
versus San Diego had a reduced odds of NMSC
(p\0.004), consistent with other reports showing a lower
incidence of NMSC in areas of low UV exposure [20].
Subject age was not associated with prevalent history of
NMSC, perhaps because our subjects were of an older age
range (65–78 years). BMI, cigarette smoking, and outdoor
walking activity were not signiﬁcantly associated with
history of NSMC [2].
We found that higher quintiles of serum 25(OH)D levels
are associated with decreased odds of NMSC when
adjusting for age, BMI, season of blood draw, and clinic
site (Ptrend = 0.032) (Table 3). This inverse association
persisted in the multivariable model when cigarette
smoking and outdoor walking activity were adjusted
(Ptrend = 0.044). The majority of the effect was observed
among men in the highest quintile of 25(OH)D who had a
47% lower odds of NMSC (OR: 0.53, 95% CI: 0.30–0.93,
p=0.026) compared to those in the lowest quintile in both
multivariable models. A 40% reduction in the odds of
NMSC was also detected when comparing Q5 versus Q1-4
(C29.9 ng/mL) in both models. Findings were similar in
analysis expressing 25(OH)D levels using standard clinical
deﬁnitions [21, 22, 23]. Subjects who had sufﬁcient levels
of 25(OH)D ([32 ng/mL) had a 43% lower odds compared
to subjects with insufﬁcient levels (OR: 0.57, 95% CI:
0.33–0.98, p=0.045) in the base model, and the associa-
tion approached but did not reach statistical signiﬁcance
after further adjustment for walking and cigarette use. The
association between 25(OH)D and NMSC risk was not
signiﬁcantly modiﬁed by age, clinic site, or walking
activity (Pinteraction[0.05).
Table 1 Baseline characteristics of men with and without non-mel-
anoma skin cancer (NMSC)
Characteristics NMSC
(n = 178)
No NMSC
(n = 930)
p-value
Mean (SD)
Age, years 73.6 (5.7) 73.2 (5.6) 0.35
BMI, kg/m
2 27.2 (3.6) 27.6 (3.7) 0.13
Daily vitamin D
intake
a,I U
182 (125) 160 (114) 0.05
Daily calcium
intake
a,I U
821 (415) 807 (385) 0.66
Outdoor walking activity 14.3 (13.1) 17.1 (18.8) 0.02
Number (%)
Current smokers 2 (1.1%) 31 (3.3%) 0.11
Spent[1 week conﬁned
to bed
8 (4.5%) 37 (3.9%) 0.75
Season of blood draw
Winter 33 (19%) 202 (22%) 0.58
Spring 47 (26%) 244 (26%)
Summer 49 (27%) 268 (29%)
Fall 49 (27%) 216 (23%)
Clinic
Minneapolis 21 (12%) 164 (17%) 0.03
Pittsburgh 28 (16%) 199 (21%)
Portland 29 (16%) 140 (15%)
Birmingham 33 (18%) 134 (14%)
Palo Alto 25 (14%) 143 (15%)
San Diego 42 (24%) 150 (16%)
Education
Elementary 2 (1.1%) 15 (1.6%) 0.54
High school 35 (20%) 212 (23%)
College 70 (39%) 381 (41%)
a Combined intake from diet and supplements
Table 2 Selected factors and the risk of non-melanoma skin cancer
(multivariable model)
Baseline covariates Odds ratio (OR)
a
and 95% CI
p-value
Age (per 1 year) 1.01 (0.98–1.04) 0.50
BMI (per 1 kg/m
2) 0.86 (0.73–1.02) 0.09
Current cigarette smoking (yes/no) 0.22 (.029–1.65) 0.14
Outdoor walking 0.99 (0.98–1.001) 0.08
Clinic site
Minneapolis vs. San Diego 0.41 (0.23–0.73) 0.003
Portland vs. San Diego 0.46 (0.27–0.78) 0.004
a OR are for each covariate in a multivariable model adjusted for
quintiles of 25(OH)D, age, BMI, season of blood draw, clinic site,
outdoor walking activity (continuous variable), and cigarette smoking
(yes/no)
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(n = 100) during the 5 year follow-up period. When we
compared subjects with 25(OH)D levels C32 ng/mL versus
those with levels\32 ng/mL, we found trends suggesting a
reduction of NMSC risk (OR: 0.72; 95% CI: 0.38–1.38,
p=0.33) in both base and multivariable models although
this did not reach statistical signiﬁcance.
Discussion
We have found that higher serum 25(OH)D levels are
associated with a decreased risk of NMSC in older Cau-
casian men. To our knowledge, this is the ﬁrst study to
examine this association, and our data argue against the
assumption that a NMSC diagnosis is a surrogate for
increased UV exposure or elevated 25(OH)D levels.
Studies in NMSC are difﬁcult as these cancers are not
reported in US national registries. One prior prospective
cohort study on vitamin D intake from diet found no
association between vitamin D and BCC risk [24]. One
explanation for these differences is that our study measured
25(OH)D3 levels which primarily reﬂect vitamin D
obtained from UV exposure and a smaller contribution
from diet and supplements.
A major strength of this study is that we are using a
large cohort of community dwelling men from diverse
geographical regions for which we have information on
season and lifestyle factors that may modify 25(OH)D
levels and NMSC risk. In addition, 25(OH)D measure-
ments were performed using mass spectroscopy, a more
precise assay compared to other techniques [16, 25]. Our
study had several limitations. NMSC outcome was
ascertained through subject self-report and not histological
conﬁrmation, although most (but not all) previous inves-
tigators have reported a positive predictive value of 80–
95% [17, 24, 26]. Our analyses were adjusted for several
skin cancer risk factors such as smoking, amount of out-
door activity, and geographic residence but we did not have
information on other skin cancer risk factors such as sub-
ject skin type, hair color, or eye color [2]. Differences in
baseline pigmentation among case and non-case groups
might affect skin cancer development and 25(OH)D as
subjects with lighter skin color would have an increased
risk for skin cancer but also an increased ability for cuta-
neous synthesis of vitamin D. Given the observational
design, the possibility of residual confounding cannot be
eliminated and we are unable to determine a causal infer-
ence between 25(OH)D levels and NMSC risk.
Our results suggest that subjects with 25(OH)D
[32 ng/ml appear to have a 40% lower risk of NMSC and
perhaps raising the 25(OH)D levels may be protective.
Laboratory studies have also shown that vitamin D may be
protective as 1.25(OH)D2 inhibits SCC cell lines, and
mice deleted for the vitamin D receptor exhibit SCC and
BCC tumors [27, 28]. Consistent with this hypothesis, we
detected a trend of reduced risk of incident NMSC among
subjects with higher 25(OH)D levels. Another possible
explanation is that NMSC subjects may have lower
25(OH)D levels due to sun avoidance behaviors after their
NMSC diagnosis. A prospective study of 25(OH)D and
incident NMSC cases is needed to further explore the
possible protective effect of vitamin D on non-melanoma
skin cancer.
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